Letter to the Editor: Implications of BRAF Mutations in dMMR Colorectal Cancers

被引：0
作者：
Sorscher, Steven [1 ]
机构：
[1] Wake Forest Sch Med, Div Oncol, Med Ctr Blvd, Winston Salem, NC 27157 USA
来源：
CURRENT TREATMENT OPTIONS IN ONCOLOGY | 2017年 / 18卷 / 09期
关键词：
dMMR; BRAF; Checkpoint;
D O I：
10.1007/s11864-017-0493-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 3 条
[1]   BRAF-Mutated Colorectal Cancer: What Is the Optimal Strategy for Treatment? [J].
Cohen, Romain ;
Cervera, Pascale ;
Svrcek, Magali ;
Pellat, Anna ;
Dreyer, Chantal ;
de Gramont, Aimery ;
Andre, Thierry .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (02)
[2]   BRAF refines clinical interpretation of mismatch repair deficiency in colorectal cancer [J].
Jensen, Lars Henrik .
COLORECTAL CANCER, 2014, 3 (01) :1-4
[3]   PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes [J].
Rosenbaum, Matthew W. ;
Bledsoe, Jacob R. ;
Morales-Oyarvide, Vicente ;
Huynh, Tiffany G. ;
Mino-Kenudson, Mari .
MODERN PATHOLOGY, 2016, 29 (09) :1104-1112
1